Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ken Solovay | M | - |
ILiAD Biotechnologies LLC
 ILiAD Biotechnologies LLC BiotechnologyHealth Technology ILiAD Biotechnologies LLC operates as a clinical stage biotechnology company, focuses on the prevention and treatment of disease caused by Bordetella Pertussis. It offers BPZE1, a live-attenuated pertussis vaccine that has completed Phase 1 human clinical trial. The company was founded by Keith Rubin in 2012 and is headquartered in New York, NY. | 12 Jahre |
| Corey Horowitz | M | 69 |
ILiAD Biotechnologies LLC
ILiAD Biotechnologies LLC BiotechnologyHealth Technology ILiAD Biotechnologies LLC operates as a clinical stage biotechnology company, focuses on the prevention and treatment of disease caused by Bordetella Pertussis. It offers BPZE1, a live-attenuated pertussis vaccine that has completed Phase 1 human clinical trial. The company was founded by Keith Rubin in 2012 and is headquartered in New York, NY. | 6 Jahre |
| Eric Edidin | M | 52 |
ILiAD Biotechnologies LLC
ILiAD Biotechnologies LLC BiotechnologyHealth Technology ILiAD Biotechnologies LLC operates as a clinical stage biotechnology company, focuses on the prevention and treatment of disease caused by Bordetella Pertussis. It offers BPZE1, a live-attenuated pertussis vaccine that has completed Phase 1 human clinical trial. The company was founded by Keith Rubin in 2012 and is headquartered in New York, NY. | 4 Jahre |
| Avi Z. Naider | M | 52 |
ILiAD Biotechnologies LLC
ILiAD Biotechnologies LLC BiotechnologyHealth Technology ILiAD Biotechnologies LLC operates as a clinical stage biotechnology company, focuses on the prevention and treatment of disease caused by Bordetella Pertussis. It offers BPZE1, a live-attenuated pertussis vaccine that has completed Phase 1 human clinical trial. The company was founded by Keith Rubin in 2012 and is headquartered in New York, NY. | - |
| Cuong Viet Do | M | 58 |
ILiAD Biotechnologies LLC
ILiAD Biotechnologies LLC BiotechnologyHealth Technology ILiAD Biotechnologies LLC operates as a clinical stage biotechnology company, focuses on the prevention and treatment of disease caused by Bordetella Pertussis. It offers BPZE1, a live-attenuated pertussis vaccine that has completed Phase 1 human clinical trial. The company was founded by Keith Rubin in 2012 and is headquartered in New York, NY. | - |
| Bin Yan | M | - |
ILiAD Biotechnologies LLC
ILiAD Biotechnologies LLC BiotechnologyHealth Technology ILiAD Biotechnologies LLC operates as a clinical stage biotechnology company, focuses on the prevention and treatment of disease caused by Bordetella Pertussis. It offers BPZE1, a live-attenuated pertussis vaccine that has completed Phase 1 human clinical trial. The company was founded by Keith Rubin in 2012 and is headquartered in New York, NY. | 8 Jahre |
| Ariel Pablos-Méndez | M | - |
ILiAD Biotechnologies LLC
ILiAD Biotechnologies LLC BiotechnologyHealth Technology ILiAD Biotechnologies LLC operates as a clinical stage biotechnology company, focuses on the prevention and treatment of disease caused by Bordetella Pertussis. It offers BPZE1, a live-attenuated pertussis vaccine that has completed Phase 1 human clinical trial. The company was founded by Keith Rubin in 2012 and is headquartered in New York, NY. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 7 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Keith Rubin
- Persönliches Netzwerk